Dian Diagnostics controlling shareholder unpledges significant stock holding

Dian Diagnostics Group, trading as Dian Diagnostics, announced that its controlling shareholder, Chen Haibin, completed the unpledging of 19,000,000 shares. This transaction represents 11.55% of Chen Haibin's total holdings and 3.04% of the company's total share capital. The pledge, originally made on August 13, 2024, was released on November 18, 2025, due to the repayment of a portion of a loan. Zhongyuan Trust Co., Ltd. was the pledgee.

Following this release, Chen Haibin's pledged shares have decreased from 84,460,000 to 65,460,000. These now account for 39.81% of his total holdings and 10.47% of the company's total share capital. Hangzhou Dian Holding Co., Ltd., an entity acting in concert with Chen Haibin, has no pledged shares.

The company stated that Chen Haibin possesses the financial capacity to repay obligations, with sources including salary, bonuses, stock dividends, and other income. The pledge release does not impact the company's operations, governance, or lead to a change in control, and there is no current risk of forced liquidation or transfer of shares.